RFK Claims 1B Medical Records Shared; AI Now a Clinical Necessity

For health system CIOs, EHR vendors, and digital health developers, RFK Jr.'s MAHA summit remarks are less about politics and more about the federal government's accelerating push toward a more open, AI-assisted care model. His claim of 1 billion shared medical records points to aggressive interoperability expectations, while his statement that it would be malpractice for doctors not to consult AI signals a shift from cautious piloting toward clinical default.

Health and Human Services Secretary Robert F. Kennedy Jr. used a MAHA summit appearance on September 29, 2026 to frame artificial intelligence and expanded patient access to medical records as the two forces that will fundamentally remake American medicine. In an interview with Armstrong Williams, Kennedy told the audience that Americans should "become the CEOs of their own health" and that "medicine is completely going to change." His most specific claim was a statistic: openly shared medical records across the industry grew from fewer than 10 million "by June" to 1 billion about 15 months into his tenure. For health IT leaders, that claim, if even partially accurate, would represent one of the fastest interoperability expansions ever asserted by a federal official.

“

Kennedy also said he met with OpenAI CEO Sam Altman earlier in the week and relayed a striking shift in Altman's guidance.

Kennedy also said he met with OpenAI CEO Sam Altman earlier in the week and relayed a striking shift in Altman's guidance. According to Kennedy, Altman said that two years ago he would not have advised anyone to take medical advice from ChatGPT or other AI tools, but that now it would be "malpractice for a doctor not to consult them." The statement is not an official HHS policy directive, but it signals how quickly the political leadership at HHS is moving toward making AI-assisted clinical practice a default expectation. It matters because HHS influences reimbursement, rulemaking, and enforcement across Medicare, Medicaid, and public health agencies.

The medical records figure deserves scrutiny. Kennedy did not specify the year for the "by June" baseline, nor did he define what qualifies as an openly shared record, what interoperability standards are being counted, or whether the 1 billion figure includes duplicate or non-clinical records. The two syndicated reports covering the summit are essentially identical and do not include independent verification. Still, the direction aligns with years of federal interoperability policy, including information-blocking rules and broader patient-mediated access efforts. If HHS now treats 1 billion shared records as a success metric, health systems, EHR vendors, and payers should expect continued pressure to open data access, expand APIs, and streamline patient consent.

Kennedy's broader record contextualizes the summit message. He was confirmed as HHS Secretary in February 2025 after joining Donald Trump's presidential campaign trail. Since taking office, he has overseen changes to the vaccine schedule and advised on the removal of dyes used in processed foods, moves that have drawn both support from the MAHA movement and criticism from public health experts. The MAHA summit, as Kennedy described it, brought together government, healthcare providers, private industry, and technology companies, creating a coalition that could push AI-driven and patient-empowered health reform more aggressively than traditional healthcare policy channels.

The market implications are significant for health IT and AI vendors. If federal messaging shifts toward treating AI consultation as a clinical standard, demand could accelerate for clinical decision support tools, ambient documentation, diagnostics, and patient-facing AI assistants. At the same time, vendors will face increased scrutiny around model accuracy, bias, explainability, data quality, and liability. Providers may be caught between a political message that AI is essential and a regulatory environment that still requires rigorous validation. Health systems that have been cautious about AI adoption may now need to document why they are not using AI in certain scenarios, while those that adopt too quickly could face patient safety and malpractice risks.